<?xml version="1.0" encoding="UTF-8"?>
<p>The idea of CP infusion was proposed in the nineteenth century when it showed immunity against diphtheria [
 <xref rid="RSOB200174C41" ref-type="bibr">41</xref>]. The existing antibodies in the blood derived from animals who were purposely immunized with a non-lethal dosage of toxins were administered to animals suffering from an ongoing infection, thus providing them with passive immunity [
 <xref rid="RSOB200174C43" ref-type="bibr">43</xref>,
 <xref rid="RSOB200174C44" ref-type="bibr">44</xref>]. It was then realized that the immune plasma provided passive immunomodulatory properties, along with pathogen neutralization, which enabled the recipient to avoid the inflammatory cascade triggered by various infectious agents [
 <xref rid="RSOB200174C44" ref-type="bibr">44</xref>,
 <xref rid="RSOB200174C45" ref-type="bibr">45</xref>]. The purification and concentration of immunoglobulins from recovered patients and healthy donors in the 1950s provided an alternative to treat severely infectious ailments as well as compromised immune conditions including allergies, autoimmune diseases and primary immunodeficiencies [
 <xref rid="RSOB200174C43" ref-type="bibr">43</xref>,
 <xref rid="RSOB200174C46" ref-type="bibr">46</xref>,
 <xref rid="RSOB200174C47" ref-type="bibr">47</xref>].
</p>
